While passenger mutations themselves do not drive cancer, they can influence cancer treatment in several ways. Some passenger mutations may affect the efficacy of targeted therapies or contribute to drug resistance. For example, mutations in genes involved in drug metabolism or transport can alter the cell's response to chemotherapy. Understanding the full mutation landscape, including passenger mutations, is vital for predicting treatment outcomes and developing effective therapies.
